logo-loader
Concepta

Concepta switches focus to UK where it is gearing up for ‘imminent’ myLotus launch

Concepta had been targeting the Chinese market initially, but new executive chairman Matthew Walls thinks it makes more sense to focus on launching the product here in the UK

mylotus
myLotus identifies the optimal time for a woman to conceive

Concepta PLC (LON:CPT) is to focus more of its resources on the UK, where it expects to launch its myLotus fertility product within the next few months.

MyLotus is an easy-to-use home test that has been developed for women who have been trying to conceive for six months or more.

It measures hormone levels in urine to give quantitative and qualitative measurements that might help explain the apparent lack of fertility.

READ: Concepta raises £2mln

The AIM-quoted firm is currently waiting on the receipt of a CE mark which will allow it to sell the product throughout the UK and Europe.

China had been the initial focus for Concepta but progress there has been “disappointing” and so new executive chairman Matthew Walls, who joined in July, has decided to switch tack.

“Whilst the positive study results from the Changhai hospital, Shanghai have helped bolster our confidence in the China product, given our limited bandwidth and revenue growth objectives our efforts will be aligned to support the successful launch of myLotus in the UK,” said Walls in Thursday’s half-year report.

Once the UK roll-out is completed, the plan is to then to start selling myLotus across Europe.

For the six months ended June 30, Concepta posted a loss of £1.49mln (H1 17: £1.08mln), reflecting the cost of getting myLotus ready for its UK launch.

The company ended the period with almost £250,000 (H1 17: £1.23mln), although a £2mln placing in August means that figure is likely looking a bit healthier now.

Quick facts: Concepta

Price: £0.02

Market: LSE
Market Cap: £6.15 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Concepta named herein, including the promotion by the Company of Concepta in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Concepta looks ahead to first births with double digit...

Top stories from the Proactive Investors UK newsroom. Fertility aid group Concepta (LON:CPT) says more than ten women using its mylotus treatment have now become pregnant with the first babies expected later this year. The company says user testimonials for the mylotus monitor and app...

on 9/7/19

2 min read